The second edition of the Nuclear Technologies for Health Symposium will feature an exceptional scientific program dedicated to advancing the fields of neurological disease imaging, tumor imaging, radionuclide targeted therapy and related topics.
Most recent articles
Stress myocardial perfusion rubidium-82 PET provides effective risk stratification in 6,037 patients, especially in women ≥ 55years, with symptoms of coronary artery disease.
8th Thematic workshop in NANTES on june 18th 2013: “Which tools for tumor targeting?”
Tumor targeting is a central aspect of the Tumor Targeting & Radiotherapies network of the Cancéropôle Grand Ouest. This network brings together many teams of west of France including chemists, biologists, radiopharmacists, physicists, nuclear medicine physicians and oncologists.
The workshop will be an opportunity not only to present scientific advances in the field oftumor targeting, so they are (...)